首頁 > 市場調查報告書 > 製藥 > 疫苗 > 大腸癌、細胞死亡、癌症疫苗分析

聯絡我們?

市場調查報告書

大腸癌、細胞死亡、癌症疫苗分析

Triple Analysis: Colorectal Cancer, Apoptosis and Cancer Vaccines

出版商	BioSeeker Group AB
出版日期	2011年12月	商品編碼	177471
內容資訊	英文 3332 Pages
價格	US $ 5175 PDF by E-mail

簡介
目錄
相關商品

大腸癌、細胞死亡、癌症疫苗分析 是由出版商BioSeeker Group AB在2011年12月所出版的。這份英文市場調查報告書包含3332 Pages 價格從美金5175起跳。

簡介

本報告針對大腸癌藥物開發目標策略、與細胞死亡及癌症疫苗機制、目的、影響分類為焦點，提供各藥劑目的策略、複合策略競爭基準、臨床實驗與分析計劃，目錄介紹如下。

第1章大腸癌

本報告範圍
以最佳治療結果與投資回收率為前提的大腸癌治療目標
新藥登場：開發階段分類大腸癌藥物目標策略
使用中的複合策略：複合策略分類競爭基準
臨床實驗與分析計劃
免責事項
藥物索引
企業索引
圖表

第2章細胞死亡

本報告範圍
以最佳治療結果與投資回收率為前提的治療目標
新藥登場：癌症細胞死亡治療藥物管道的特定藥劑目標策略，是否有成熟的藥物目標策略、獨特性、有臨床評價
使用中的複合策略：複合策略分類競爭基準
藥物影響與胜肽的癌適應症
分析計劃：癌症細胞死亡治療臨床實驗競爭基準
藥物索引
企業索引
圖表

第3章癌症疫苗

本報告範圍
以最佳治療結果與投資回收率為前提的治療目標
新藥登場：開發階段分類癌症疫苗藥物目的策略
使用中的複合策略：複合策略分類競爭基準
臨床實驗與分析計劃
藥物影響與癌症疫苗的癌症適應症
免責事項
藥物索引
企業索引
圖表

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.

Key Topics Covered:

Part I: Colorectal Cancer

5.1. The Scope of this Report
6. Consider the Therapeutic Target Among Colorectal Cancer Drugs for the Highest Therapeutic Outcome and Return on Investment (210 Drug Targets)
7. Emerging New Products to Established Ones: Drug Target Strategies of Colorectal Cancer Drugs by their Highest Stage of Development (205 Drug Target Strategies and 347 Colorectal Cancer Drugs)
8. Compound Strategies at Work: Competitive Benchmarking of Colorectal Cancer Drugs by Compound Strategy (8 Compound Strategies)
9. Pipeline and Portfolio Planning: Competitive Benchmarking of the Colorectal Cancer Drug Pipeline by Investigator (182 Companies)
10. Disclaimer
11. Drug Index
12. Company Index

Figures: Includes 6 Figures
Tables: Includes 242 Tables
Total Number of Pages: 1,056

Part II: Apoptosis

5.1. The Scope of this Report
6. Consider the Therapeutic Target for the Highest Therapeutic Outcome and Return on Investment (146 Drug Targets)
7. The Rise of New Products: How Mature, Unique and Clinically Validated are the Drug Target Profiles Identified in the Cancer Apoptotic Therapeutic Pipeline? (120 Drug Target Strategies and 171 Drugs)
8. Compound Strategies at Work: Competitive Benchmarking of Apoptotic Drugs in Oncology by Compound Type (7 Different Compound Strategies)
9. Selecting Cancer Indications for Apoptotic Therapeutics (53 Cancer Indications)
10. Portfolio Planning: Competitive Benchmarking of Apoptotic Cancer Therapeutic Pipeline by Investigator (125 Investigators)
12. Drug Index
13. Company Index

Figures: Includes 6 Figures
Tables: Includes 248 Tables
Total Number of Pages: 803

Part III: Cancer Vaccines

5.1. The Scope of this Report
6. Consider the Therapeutic Target Among Cancer Vaccine Drugs for the Highest Therapeutic Outcome and Return on Investment (94 Drug Targets)
7. Emerging New Products to Established Ones: Drug Target Strategies of Cancer Vaccine Drugs by their Highest Stage of Development (91 Drug Target Strategies and 155 Cancer Vaccine Drugs)
8. Compound Strategies at Work: Competitive Benchmarking of Cancer Vaccine Drugs by Compound Strategy (7 Compound Strategies)
9. Selecting Cancer Indications for Cancer Vaccine Drugs (42 Cancer Indications)
10. Pipeline and Portfolio Planning: Competitive Benchmarking of the Cancer Vaccine Drug Pipeline by Investigator (99 Investigators)
11. Disclaimer
12. Drug Index
13. Company Index

Figures: Includes 6 Figures
Tables: Includes 205 Tables
Total Number of Pages: 659

Featured Companies:

This Report Includes the Following Companies:

Abbott
AC Immune
Access
Adaptimmune
Adherex
Aduro BioTech
Advanced Life Sciences
Advaxis
AEgera
Aeterna Zentaris
Affimed Therapeutics
Aida Pharmaceuticals
Akela Pharma
Alchemia
Alethia Biotherapeutics
Allos Therapeutics
Alnylam
AlphaVax
Alseres Pharmaceuticals
Ambrilia Biopharma
Amgen
Anavex Life Sciences
Antisense Pharma
Antisoma
Aphios
ApopLogic Pharmaceuticals
Apotex
Apthera
Ariad
Arno Therapeutics
ArQule
Array BioPharma
Astellas
AstraZeneca
Attenuon
AVEO
AVI BioPharma
Bavarian Nordic
Bayer
Bellicum Pharmaceuticals
Betapharma
BioAlliance Pharma
BioAxone
Biocompatibles
Biogen Idec
BioInvent
Bionovo
BioNumerik
Biostar
BioVex
Boehringer Ingelheim
Bristol-Myers Squibb
BTG
Cadila
Can-Fite BioPharma
Cancer Advances
Cancer Research Technology
Celator Pharmaceuticals
Celera
Celgene
Cell Genesys
Cell Therapeutics
Celldex Therapeutics
Cellmid
Celsion
Celtic Pharma
Center of Molecular Immunology
Cephalon
CG Therapeutics
ChemGenex Pharmaceuticals
ChemoCentryx
Choongwae
Circadian Technologies
Clavis Pharma
Cosmo Pharmaceuticals
CSL
CuraGen
CureTech
Curis
Cyclacel
Cylene Pharmaceuticals
Cynvec
CytImmune Sciences
Cytochroma
Cytokinetics
Daewoong
Daiichi Sankyo
Dainippon Sumitomo Pharma
Deciphera Pharmaceuticals
Dendreon
DeveloGen
Dynavax Technologies
EGEN Inc
Eisai
Eli Lilly
Enkam Pharmaceuticals
EntreMed
Enzon
Epeius Biotechnologies
EpiCept
Etubics
Exelixis
FasTrack Pharmaceuticals
Genentech
Generex
Genmab
GenOdyssee Pharmaceuticals
Genta
GENTICEL
GenVec
Genzyme
Geron
Gilead Sciences
GlaxoSmithKline
Gliknik
GlobeImmune
GlycoGenesys
Gradalis
Green Cross
Heidelberg Pharma
Hoffmann-La Roche
Human Genome Sciences
Ichor Medical Systems
Idera Pharmaceuticals
IkerChem
ImmunoCellular Therapeutics
Immunocore
ImmunoFrontier
Immunomedics
Immunotope
Incyte Corporation
Infinity Pharmaceuticals
Innate Pharma
InNexus Biotechnology
Inovio
Insmed
Insys Therapeutics
Intradigm
Introgen Therapeutics
Ipsen
ISA Pharmaceuticals
Isis Pharmaceuticals
ISU ABXIS
Ivy Medical Chemicals
Jennerex Biotherapeutics
Johnson & Johnson
Kalypsys
Kiadis
Kyowa Hakko Kirin
Labopharm
Leo
Lorus Therapeutics
MacroGenics
Meda
Medical Marketing International
MediGene
Medisyn Technologies
Menarini
Merck & Co
Merck KGaA
Merrimack
Mersana Therapeutics
MethylGene
Micromet
Mitsubishi Tanabe Pharma
MolMed
Mologen
Nektar Therapeutics
Nemod Biotherapeutics
NeoPharm
Neovacs
Nerviano Medical Sciences
NicOx
NIH
Nippon Kayaku
Non-industrial source
Northwest Biotherapeutics
Novartis
NovaRx
Novelix
Novogen
Nycomed Pharma
OncoGenex Pharmaceuticals
OncoMed
OncoMune
Onconova
OncoTherapy Science
Oncothyreon
Oncovir
Oncozyme Pharma
Onyvax
Orca Therapeutics
Orchestra Therapeutics
OSI Pharmaceuticals
Oxford BioMedica
OXiGENE
PanaGin
Pepscan Systems
Pepscan Therapeutics
Pfizer
Pharmaclon
Pharmacyclics
PharmaGap
PharmaMar
Pharmexa
Pharminox
Philogen
Pierre Fabre
Plexxikon
POZEN
Prima Biomed
Pro-Pharmaceuticals
Progenics Pharmaceuticals
Protherics
Radient Pharmaceuticals
Reata Pharmaceuticals
Receptor BioLogix
Regeneron
Regulon
responsif
Rigel
Sanofi-Aventis
Santaris Pharma
Sareum
Scancell
SciClone Pharmaceuticals
Semafore Pharmaceuticals
Shire
Sigma-Tau
Simcere Pharmaceuticals
Spirogen
SRI International
SuperGen
Supratek Pharma
Switch Pharma
SynDevRx
Synta Pharmaceuticals
Taiho
Takeda
Talon Therapeutics
TapImmune
Targepeutics
Tau Therapeutics
Taxolog
Telik
Thallion Pharmaceuticals
The Genetics Company
Therion Biologics
ThromboGenics
Tigris Pharmaceuticals
Titan Pharmaceuticals
TopoTarget
Tracon Pharmaceuticals
Transgene
Trion Pharma
United Biomedical
Vaccinex
Vascular Biogenics
Vaxil BioTherapeutics
Vaxon Biotech
VaxOnco
Vectura
Vertex Pharmaceuticals
Vical
Wilex
VioQuest
VioQuest Pharmaceuticals
Viragen
Viralytics
Virionics
ViroMed
ViroTarg
Wyeth
Xerion
Yakult Honsha
YM BioSciences
Zensun

ZymoGenetics

Featured Drugs:

A Shortlist of Drugs Included are:

2-methoxyestradiol
ABT-263
ADXS11-001
AE-37
AEG-35156
aflibercept
afutuzumab
ALVAC-CEA/B7.1
alvocidib
Angiozyme
Apomab
ARQ-197
AS-1411
astuprotimut-r
atiprimod dimaleate
ATN-224
AVX-701
belagenpumatucel-L
belinostat
bevacizumab
BP-GMAX-CD1
brivanib alaninate
BZL-101
Cadi-05
canfosfamide hydrochloride
capecitabine
catumaxomab
CB-10-01
CBLC-102
CEA-TRICOM
cediranib
cenersen
cetuximab
CG-201
cintredekin besudotox
CMLVAX-100
combretastatin A-4 prodrug
conatumumab
CS-1008
CTL901
CTP-37
CVac
DCVax-prostate
doxifluridine
dulanermin
E-75
everolimus
fowlpox-PSA vaccine
GCS-100LE
GRN-163L
GRNVAC1
GV-1001
GV-1002
GVAX
GVX-3322
HE-3235
Her-2/Neu peptides
idronoxil
IGN-101
ImmunoVEX tri-melan
IMO-2055
indisulam
INGN-225
INGN-241
INGN-401
interferon gamma
irinotecan bead
irinotecan hydrochloride
ISIS-23722
kahalalide F
lonaprisan
lumiliximab
MAGE-3-TK
mapatumumab
ME-103
MGCD-0103
MGN-1601
MGN-1703
MKC-1
motexafin gadolinium
MSI vaccine
MVA-BN
MVA-BN Her-2 vaccine
Norelin
oblimersen sodium
Onyvax-105
OTS-102
panitumumab
panobinostat
PANVAC-VF
PARP inhibitors
PAT-SC1
patupilone
PCI-24781
pDOM-PSMA27
PEP-223
perifosine
plitidepsin
poly-ICLC
PR1:169-177 peptide
PROSTVAC
PX-104.1
quarfloxacin
raltitrexed
ramucirumab
regorafenib
retaspimycin
Reximmune-C
Rh-Apo2L
rindopepimut
sagopilone
SAI-EGF
seliciclib
Stimuvax
tegafur + uracil
tegafur + uracil + leucovorin
TG-4001
TG-4010
thymalfasin
tigapotide triflutate
TLN-232
triciribine
TroVax
TRU-016
TS-1
verpasep caltespen
voreloxin
VX-001
VX-944
XL-647

ZYC-300

簡介
目錄
相關商品

使用指南產品及服務須知網站導覽

星期一到星期五 / 9:30am - 6:00pm
TEL: 02-2729-4219 (+886-2-2729-4219)
E-mail: tw-info@gii.co.jp

大腸癌、細胞死亡、癌症疫苗分析

Triple Analysis: Colorectal Cancer, Apoptosis and Cancer Vaccines